IL13RA2 and central nervous system cancer: Unfortunately, despite enhanced recognition of glioma cells, greater proliferative capacity and increased production of cytokines, the improved T cell persistence was associated with recurrence of gliomas with down-regulated IL-13Rα2 expression.